Home   >  
Cell Cycle/DNA Damage
  >  
PPAR

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

PPAR

Chemical Structure Cat. No. Product Name CAS No.
Edaglitazone Chemical Structure
BCP26908 Edaglitazone 213411-83-7
Edaglitazone is a PPARγ agonist potentially for the treatment of type 2 diabetes. Edarglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse.
PTGR2-IN-1 Chemical Structure
BCP48929 PTGR2-IN-1 349093-44-3
PTGR2-IN-1 is a potent PTGR2 inhibitor with an IC50 of ~0.7 μM.
Elafibranor Chemical Structure
BCP31152 Elafibranor 824932-88-9
Elafibranor (GFT505) is an agonist of the peroxisome proliferator-activated receptor-α(PPAR-alpha) and peroxisome proliferator-activated receptor-δ(PPAR-δ). It improves insulin sensitivity, glucose homeostasis, and lipid metabolism and reduces inflammation.
Bocidelpar Chemical Structure
BCP45760 Bocidelpar 2095128-20-2
Bocidelpar is a peroxisome proliferator-activated receptor (PPAR) delta agonist.
SR1664 Chemical Structure
BCP45759 SR1664 1338259-05-4
SR1664 is a potent and selective PPARγ inhibitor with potential antidiabetic activity.
AMG-131 Chemical Structure
BCP45654 AMG-131 315224-26-1
AMG-131 is a hypoglycemic agent. It is a potent PPARγ partial agonist that displays robust glucose-lowering activity in rodent models of diabetes while exhibiting a reduced side-effects profile compared to marketed TZDs.
NXT629 Chemical Structure
BCP44937 NXT629 1454925-59-7
NXT629 is a potent, selective, and competitive PPAR-α antagonist.
EHP-101 Chemical Structure
BCP43165 EHP-101 1818428-24-8
EHP-101 is an oral lipidic formulation of VCE-004.8 that has shown efficacy in several preclinical models of autoimmune, inflammatory, fibrotic, and neurodegenerative diseases.
Fmoc-L-Leucine Chemical Structure
BCP39156 Fmoc-L-Leucine 35661-60-0
NPC 15199 is an amino acid derivative.
Lobeglitazone Chemical Structure
BCP37672 Lobeglitazone 607723-33-1
Lobeglitazone is an agent belonging to the glitazone class of antidiabetic agents with antihyperglycemic activity. Besides its activation of peroxisome proliferator-activated receptor (PPAR) gamma, lobeglitazone is also a potent agonist for PPARalpha.
123下一页末页共 57 条记录 1 / 6 页 
0086-13720134139